Epilepsy and driving

Rules vary from state to state

In the European Union, some member states, including the United Kingdom, require a one year period of freedom from seizures before granting or renewing a driving licence although most require a two year period. More variation exists about exceptions where people with active epilepsy may drive (for example, seizures during sleep, myoclonic seizures, simple partial seizures, and seizures only on awakening). In the United Kingdom, for example, the only exception to the rule is seizures occurring solely during sleep, with this pattern established for three years. But this pattern needs to be established for two years in Belgium and only one year in the Netherlands. The Republic of Ireland also requires the pattern to be established for one year, and the Netherlands allows people who have seizures during wakefulness that are not felt to impair driving ability (simple partial seizures) to drive. French legislation allows people with seizures only on awakening to drive. Regulations on commercial driving and supportive laboratory (electroencephalographic) criteria differ widely. In most countries of the European Union, the onus for reporting seizures to the driving authorities is on the individual.

Patients' or authorities' perspectives?

The issue of epilepsy and driving may have differing emphases depending on whose perspective is being considered. From a patient's perspective, the risk of seizure related accidents (rate ratio 1.8, 95% confidence interval 1.7 to 2.0)5 and the risk of serious accidents (odds ratio 1.4, 95% confidence interval 1.0 to 1.8)6 when epilepsy is active might be too high. Fewer than half of all epileptic seizures, however, occur in the context of established epilepsy (defined as repeated unprovoked seizures)7; the remainder consists of acute symptomatic seizures and single unprovoked seizures. Acute symptomatic seizures can be prevented by adequate control of the cause, whereas single unprovoked seizures have a smaller probability of relapse after the first 12 months.8 Even among people with active epilepsy, several epilepsy syndromes exist (for example, nocturnal tonic-clonic epilepsy or epilepsies with simple partial seizures), which may be compatible with non-commercial driving.

From the perspective of a health authority or insurance, the proportion of accidents attributable to active epileptic seizures is extremely low, ranging from 0.02% to 0.2%.9 10 In this context, epilepsy compares favourably with alcohol abuse (up to 31%) and young age (up to 24%).10 Mandatory reporting of epilepsy by doctors to the driving authorities, where required, may have negative implications as it affects the relationship between doctor and patient or may expose a doctor who fails to report a patient's epilepsy to the risk of prosecution.

Harmonise the rules

An effort should be made by the driving authorities within the European Union to set common and more flexible rules considering epilepsy and seizures as a spectrum of clinical conditions, many of which are fully or partly compatible with non-commercial driving. Different periods of seizure freedom could be considered as a prerequisite for granting driving licences, depending on the type of epilepsy and seizure patterns. Acute symptomatic seizures should be considered separately, and may be compatible with non-commercial driving providing the underlying clinical condition is adequately identified and controlled. Likewise, patients with single unprovoked seizures should forego driving only for 12 months. In contrast, more strict rules should be set for commercial driving. Factors that determine risk of driving related accidents are the amount of time spent driving, number of previous accidents, and whether or not passengers are being transported.11 The driving authorities should consider carefully these variables when defining the length of the minimum seizure free period deemed necessary to grant or renew a driving licence.

All these issues have been dealt with in a review paper.12 They will also be discussed in a scientific report on epilepsy and driving in Europe, which is in preparation by the advisory board to the driving licence committee of the European Union, leading to the harmonisation of rules. For now, Europe wide legislation is still awaited.

A general practitioner seeing a person with newly diagnosed or suspected epilepsy who drives must encourage compliance with the national rules. A person with epilepsy who has driving privileges in one European country will not necessarily be entitled to drive in another country. Therefore, a detailed list of individual national rules on epilepsy and driving needs to be easily available, and doctors should alert their patients to the need to comply with these rules.